167 related articles for article (PubMed ID: 2665869)
21. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
22. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
23. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome.
Veyradier A; Obert B; Haddad E; Cloarec S; Nivet H; Foulard M; Lesure F; Delattre P; Lakhdari M; Meyer D; Girma JP; Loirat C
J Pediatr; 2003 Mar; 142(3):310-7. PubMed ID: 12640381
[TBL] [Abstract][Full Text] [Related]
24. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
[TBL] [Abstract][Full Text] [Related]
25. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
[TBL] [Abstract][Full Text] [Related]
27. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Tsai HM; Chandler WL; Sarode R; Hoffman R; Jelacic S; Habeeb RL; Watkins SL; Wong CS; Williams GD; Tarr PI
Pediatr Res; 2001 May; 49(5):653-9. PubMed ID: 11328948
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Baker KR; Moake JL
Curr Opin Pediatr; 2000 Feb; 12(1):23-8. PubMed ID: 10676770
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
Bosch T; Wendler T
Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
[TBL] [Abstract][Full Text] [Related]
30. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Mori Y; Wada H; Okugawa Y; Tamaki S; Nakasaki T; Watanabe R; Gabazza EC; Nishikawa M; Minami N; Shiku H
Clin Appl Thromb Hemost; 2001 Jan; 7(1):5-9. PubMed ID: 11190905
[TBL] [Abstract][Full Text] [Related]
31. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
[TBL] [Abstract][Full Text] [Related]
32. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
33. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Solenthaler M; Lämmle B
Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
[TBL] [Abstract][Full Text] [Related]
34. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
[TBL] [Abstract][Full Text] [Related]
35. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.
George JN; Vesely SK; Terrell DR
Semin Hematol; 2004 Jan; 41(1):60-7. PubMed ID: 14727260
[TBL] [Abstract][Full Text] [Related]
36. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
37. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Elliott MA; Nichols WL
Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
[TBL] [Abstract][Full Text] [Related]
38. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
39. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
Sánchez Avalos JC
Medicina (B Aires); 2000; 60(1):46-58. PubMed ID: 10835700
[TBL] [Abstract][Full Text] [Related]
40. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
Myers L
Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]